| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:0042526 | BP | positive regulation of tyrosine phosphorylation of Stat6 protein | Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat6 protein. |
PIBF1 |
GO:0042527 | BP | negative regulation of tyrosine phosphorylation of Stat6 protein | Any process that stops, prevents, or reduces the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a Stat6 protein. |
PTPN2 |
GO:0042531 | BP | positive regulation of tyrosine phosphorylation of STAT protein | Any process that activates or increases the frequency, rate or extent of the introduction of a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein. |
LYN, CCL5, HCLS1 |
GO:0042535 | BP | positive regulation of tumor necrosis factor biosynthetic process | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis. |
TLR4, HSPB1, CYBB, THBS1, TNFRSF8, MAPKAPK2, TLR1 |
GO:0042536 | BP | negative regulation of tumor necrosis factor biosynthetic process | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis. |
BCL3, IL10, LILRB1, GHSR, GHRL, ERRFI1 |
GO:0042538 | BP | hyperosmotic salinity response | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment. |
TRPV4 |
GO:0042541 | BP | hemoglobin biosynthetic process | The chemical reactions and pathways resulting in the formation of hemoglobin, an oxygen carrying, conjugated protein containing four heme groups and globin. |
INHA, INHBA, HIF1A |
GO:0042542 | BP | response to hydrogen peroxide | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus. |
KPNA4, LDHA, HP, ADA, COL1A1, CRYAB, JUN, GPX1, HMOX1, PDGFRB, BCL2, HSPD1, EEF2, FOSL1, AREG, SDC1, DUSP1, STAR, PPP2CB, HBB, HBA1, ADAM9, NR4A3, BAD, PDCD10, TXNIP, GLRX2, STK24 |
GO:0042551 | BP | neuron maturation | A developmental process, independent of morphogenetic (shape) change, that is required for a neuron to attain its fully functional state. |
KDM1A, CLN5, RB1, NR4A2, CDKN1C |
GO:0042552 | BP | myelination | The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
DHH, TSPAN2, TNFRSF21, TGFB1, ERBB2, EGR2, ZNF24, MAL, PMP22, EIF2B5, GPR126, SERINC5, QKI, JAM3, EIF2B4, MYO5A |
GO:0042554 | BP | superoxide anion generation | The enzymatic generation of superoxide, the superoxide anion O2- (superoxide free radical), or any compound containing this species, by a cell in response to environmental stress, thereby mediating the activation of various stress-inducible signaling pathways. |
CYBB, EDN1, NCF2, NOX5, NOX4, DUOX1 |
GO:0042555 | CC | MCM complex | A hexameric protein complex required for the initiation and regulation of DNA replication. |
MCM3, MCM4, MCM5, MCM7, MCM2, MCM6, TONSL |
GO:0042558 | BP | pteridine-containing compound metabolic process | The chemical reactions and pathways involving any compound containing pteridine (pyrazino(2,3-dipyrimidine)), e.g. pteroic acid, xanthopterin and folic acid. |
MTR |
GO:0042562 | MF | hormone binding | Interacting selectively and non-covalently with any hormone, naturally occurring substances secreted by specialized cells that affect the metabolism or behavior of other cells possessing functional receptors for the hormone. |
NPR3, NPR2, CALR, MTNR1A, AMHR2 |
GO:0042564 | CC | NLS-dependent protein nuclear import complex | A protein complex which usually consists of three components, e.g. in Xenopus, the importin alpha and beta-subunits and any protein which has a nuclear localization sequence (NLS). The complex acts to import proteins with an NLS into the nucleus through a nuclear pore. |
MYBBP1A |
GO:0042567 | CC | insulin-like growth factor ternary complex | A complex of three proteins, which in animals is approximately 150kDa and consists of the insulin-like growth factor (IGF), the insulin-like growth factor binding protein-3 (IGFBP-3), or -5 (IGFBP-5) and an acid-labile subunit (ALS). The complex plays a role in growth and development. |
IGF1, IGFBP3, IGFBP5 |
GO:0042571 | CC | immunoglobulin complex, circulating | An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component. |
IGLL5 |
GO:0042572 | BP | retinol metabolic process | The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A. |
DHRS3, ALDH1A2, ALDH1A1, RBP4, TTR, ADH7, AKR1C3, ALDH1A3, CYP1B1, RDH10, RDH13, RDH11, DGAT2, DHRS9, DHRS4 |
GO:0042573 | BP | retinoic acid metabolic process | The chemical reactions and pathways involving retinoic acid, one of the three components that makes up vitamin A. |
CYP26A1, ALDH1A2, ADH7, ALDH1A3, ALDH8A1, SCPEP1 |
GO:0042574 | BP | retinal metabolic process | The chemical reactions and pathways involving retinal, a compound that plays an important role in the visual process in most vertebrates. In the retina, retinal combines with opsins to form visual pigments. Retinal is one of the forms of vitamin A. |
ALDH1A2, AKR1C3, ALDH1A3, AKR1C1, CYP1B1, RDH10, RDH11, ALDH8A1 |
GO:0042577 | MF | lipid phosphatase activity | Catalysis of the reaction: a phospholipid + H2O = a lipid + phosphate. |
PLPP1, PLPP3, PLPPR4, PLPPR2, INPP5K |
GO:0042578 | MF | phosphoric ester hydrolase activity | Catalysis of the reaction: RPO-R' + H2O = RPOOH + R'H. This reaction is the hydrolysis of any phosphoric ester bond, any ester formed from orthophosphoric acid, O=P(OH)3. |
PGAP1 |
GO:0042581 | CC | specific granule | Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase. |
SNAP23, ANXA3, ANXA11, CLCN3, CRISP3, ADAM8, STX4, STX3, STXBP2, OLFM4 |
GO:0042582 | CC | azurophil granule | Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid. |
SNAP23, STX7, MPO, HEXA, DEFA4, ANXA11, STX3, STXBP2 |
GO:0042583 | CC | chromaffin granule | Specialized secretory vesicle found in the cells of adrenal glands and various other organs, which is concerned with the synthesis, storage, metabolism, and secretion of epinephrine and norepinephrine. |
CLU |
GO:0042584 | CC | chromaffin granule membrane | The lipid bilayer surrounding a chromaffin granule, a specialized secretory vesicle found in the cells of adrenal glands and various other organs, which is concerned with the synthesis, storage, metabolism, and secretion of epinephrine and norepinephrine. |
SYT1, SRI |
GO:0042585 | CC | germinal vesicle | The enlarged, fluid filled nucleus of a primary oocyte, the development of which is suspended in prophase I of the first meiotic division between embryohood and sexual maturity. |
AURKA, MARCKS |
GO:0042587 | CC | glycogen granule | Cytoplasmic bead-like structures of animal cells, visible by electron microscope. Each granule is a functional unit with the biosynthesis and catabolism of glycogen being catalyzed by enzymes bound to the granule surface. |
PPP1R3D, FASN, PCYT1A, PPP1CA, PPP1CB, PPP1R3B |
GO:0042588 | CC | zymogen granule | A membrane-bounded, cytoplasmic secretory granule found in enzyme-secreting cells and visible by light microscopy. Contain zymogen, an inactive enzyme precursor, often of a digestive enzyme. |
GNAI3, SRGN, HSPD1 |
GO:0042589 | CC | zymogen granule membrane | The lipid bilayer surrounding a zymogen granule. |
RAB27B, SCAMP1, TMED10, VAMP2, STX3, TMED2, STXBP2, DMBT1 |
GO:0042592 | BP | homeostatic process | Any biological process involved in the maintenance of an internal steady state. |
NR5A2, ANG, MPV17, SMAD1, CREBBP |
GO:0042593 | BP | glucose homeostasis | Any process involved in the maintenance of an internal steady state of glucose within an organism or cell. |
POMC, INS, RBP4, IL6, INSR, GPI, NGFR, NMB, SLC2A4, CYP11B1, PTPN2, HNF1A, CNR1, IGFBP5, AKT1, SSTR5, ADRA1B, PCK1, IRS1, G6PC, PPARG, STAT3, LEP, LEPR, MTNR1B, DHPS, PRKAA2, SESN3, RPS6, PTPN11, SOX4, PTCH1, STK11, ADIPOQ, CRY1, PDK4, HIF1A, ADIPOR2, ERO1B, BAD, ADIPOR1, NR1H4, INPP5K, ASPSCR1, TRPV4, TCF7L2, GPRC5B, MBD5, RPH3AL, STXBP5L |
GO:0042594 | BP | response to starvation | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a starvation stimulus, deprivation of nourishment. |
GNPAT, ULK1, GCG, PFKFB1, ZFP36, CAD, ADSL, SSTR1, ADM, DDIT3, HMGCL, PPARG, OXCT1, DHODH, FSTL1, PDK4, AACS, ADSSL1, TBC1D5, PPARGC1A |
GO:0042596 | BP | fear response | The response of an organism to a perceived external threat. |
ADRB1 |
GO:0042599 | CC | lamellar body | A membrane-bounded organelle, specialized for the storage and secretion of various substances (surfactant phospholipids, glycoproteins and acid phosphates) which are arranged in the form of tightly packed, concentric, membrane sheets or lamellae. Has some similar properties to, but is distinct from, a lysosome. |
SFTPC |
GO:0042602 | MF | riboflavin reductase (NADPH) activity | Catalysis of the reaction: reduced riboflavin + NADP+ = riboflavin + NADPH + 2 H+. |
BLVRB |
GO:0042605 | MF | peptide antigen binding | Interacting selectively and non-covalently with an antigen peptide. |
HLA-B, HLA-DRA, HLA-DQA1, HLA-DQB1, HLA-E, HLA-DPA1, HLA-A, HLA-F, HLA-DRB3, SLC7A9, SLC7A5, DHCR24, HLA-DRB5, CD209, SLC7A8 |
GO:0042608 | MF | T cell receptor binding | Interacting selectively and non-covalently with a T cell receptor, the antigen-recognizing receptor on the surface of T cells. |
FYN, DOCK2 |
GO:0042609 | MF | CD4 receptor binding | Interacting selectively and non-covalently with a CD4, a receptor found on the surface of T cells, monocytes and macrophages. |
PLSCR1, FYN, PLSCR4 |
GO:0042610 | MF | CD8 receptor binding | Interacting selectively and non-covalently with a CD8, a receptor found on the surface of thymocytes and cytotoxic and suppressor T-lymphocytes. |
FYN |
GO:0042612 | CC | MHC class I protein complex | A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
HLA-B, HLA-E, HLA-G, HLA-A, HLA-F, B2M, MR1 |
GO:0042613 | CC | MHC class II protein complex | A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen. |
HLA-DRA, HLA-DQA2, HLA-DQA1, HLA-DQB1, CD74, HLA-DRB4, HLA-DOB, HLA-DPA1, HLA-DMB, HLA-DRB3, HLA-DRB5 |
GO:0042622 | CC | photoreceptor outer segment membrane | The membrane surrounding the outer segment of a vertebrate photoreceptor. |
DHRS3, OPN1SW, CNGA1, GNB1, NAPEPLD, PHLPP2 |
GO:0042623 | MF | ATPase activity, coupled | Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction directly drives some other reaction, for example ion transport across a membrane. |
VPS4B, HSPA1A, HSPA1B, HSPA6, NSF, CCT8, MYO1E |
GO:0042624 | MF | ATPase activity, uncoupled | Catalysis of the reaction: ATP + H2O = ADP + phosphate; this reaction is not directly coupled to any other reaction. |
ATP6V1F |
GO:0042625 | MF | ATPase coupled ion transmembrane transporter activity | Catalysis of the transfer of an ion from one side of a membrane to the other, driven by the reaction: ATP + H2O = ADP + phosphate. |
ATP6V0E1, ATP6V1F |
GO:0042626 | MF | ATPase activity, coupled to transmembrane movement of substances | Catalysis of the reaction: ATP + H2O = ADP + phosphate, to directly drive the active transport of a substance across a membrane. |
ABCD4, ABCA8, ABCA1, ABCD3, ABCC1, ABCA6, ABCA5, ABCG8, ABCB10, ATP6V1D |
GO:0042627 | CC | chylomicron | A large lipoprotein particle (diameter 75-1200 nm) composed of a central core of triglycerides and cholesterol surrounded by a protein-phospholipid coating. The proteins include one molecule of apolipoprotein B-48 and may include a variety of apolipoproteins, including APOAs, APOCs and APOE. Chylomicrons are found in blood or lymph and carry lipids from the intestines into other body tissues. |
APOA1, APOE, APOA2, APOC1, APOC3, APOH, APOB, LPL, APOBR, APOA5, LSR |
GO:0042628 | BP | mating plug formation | The deposition of a plug of sperm or other gelatinous material into the opening of the vulva by a male at the termination of copulation. Probably acts to prevent subsequent matings by other males. |
SERPINE2 |
GO:0042629 | CC | mast cell granule | Coarse, bluish-black staining cytoplasmic granules, bounded by a plasma membrane and found in mast cells and basophils. Contents include histamine, heparin, chondroitin sulfates, chymase and tryptase. |
SNAP23, PIK3CD, ANXA1, LYN, SRGN, KIT, AKR1B1, CXCR2, PIK3CG, CPLX2, NR4A3, S100A13 |
GO:0042631 | BP | cellular response to water deprivation | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of water. |
AQP2 |
GO:0042632 | BP | cholesterol homeostasis | Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell. |
NR5A2, NPC1, LRP5, ABCA1, LDLR, APOA1, APOE, APOA2, APOC3, APOB, FABP3, LPL, FABP4, XBP1, CD24, G6PC, SOAT1, NR1H2, NPC2, CAV1, AKR1C1, MALL, NR1H3, IL18, ACSM3, TMEM97, LDLRAP1, LAMTOR1, APOA5, PCSK9, SCARB1, MYLIP, DGAT2, ABCG8, LIPG |
GO:0042633 | BP | hair cycle | The cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair; one of the collection or mass of filaments growing from the skin of an animal, and forming a covering for a part of the head or for any part or the whole of the body. |
KRT16, PTGS2, PPP1R13L |
GO:0042634 | BP | regulation of hair cycle | Any process that modulates the frequency, rate or extent of the cyclical phases of growth (anagen), regression (catagen), quiescence (telogen), and shedding (exogen) in the life of a hair. |
ARNTL, PER1, NIPBL, FA2H |
GO:0042637 | BP | catagen | The regression phase of the hair cycle during which cell proliferation ceases, the hair follicle shortens, and an anchored club hair is produced. |
TGFB2 |
GO:0042641 | CC | actomyosin | Any complex of actin, myosin, and accessory proteins. |
MYH9, HDAC4, DBN1, CDC42BPA, KAT2B, MYO5A, CDC42BPB |
GO:0042643 | CC | actomyosin, actin portion | The actin part of any complex of actin, myosin, and accessory proteins. |
ACTC1 |
GO:0042645 | CC | mitochondrial nucleoid | The region of a mitochondrion to which the DNA is confined. |
KIAA0391, CLPX, SLC25A5, DBT, MPG, LRPPRC, VDAC2, ACADVL, DNA2, POLG, HADHB, TFAM, SSBP1, GRSF1, DHX30, SUPV3L1, TEFM, PEO1, MTERF1, ELAC2, UQCC2, DDX28, ATAD3A, POLDIP2 |
GO:0042658 | MF | MHC class II protein binding, via antigen binding groove | Interacting selectively and non-covalently with the antigen binding groove of major histocompatibility complex class II molecules. |
CD74 |
GO:0042659 | BP | regulation of cell fate specification | Any process that mediates the adoption of a specific fate by a cell. |
LMO4 |
GO:0042660 | BP | positive regulation of cell fate specification | Any process that activates or enables a cell to adopt a specific fate. |
FGF2 |
GO:0042662 | BP | negative regulation of mesodermal cell fate specification | Any process that stops, prevents, or reduces the frequency, rate or extent of mesoderm cell fate specification. |
DKK1, SOX17 |
GO:0042663 | BP | regulation of endodermal cell fate specification | Any process that mediates the specification of a cell into an endoderm cell. |
DKK1, DUSP6 |
GO:0042666 | BP | negative regulation of ectodermal cell fate specification | Any process that restricts, stops or prevents a cell from specifying into an ectoderm cell. |
FZD7 |
GO:0042668 | BP | auditory receptor cell fate determination | The process in which a cell becomes capable of differentiating autonomously into an auditory hair cell regardless of its environment; upon determination, the cell fate cannot be reversed. |
HES1 |
GO:0042692 | BP | muscle cell differentiation | The process in which a relatively unspecialized cell acquires specialized features of a muscle cell. |
BIN1, RORA, HIRA, H3F3A, ANKRD1, SMARCD3, GLMN, QKI, ASF1A |
GO:0042693 | BP | muscle cell fate commitment | The process in which the cellular identity of muscle cells is acquired and determined. |
TBX1 |
GO:0042698 | BP | ovulation cycle | The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years. |
EGFR, SERPINF1, TYRO3 |
GO:0042699 | BP | follicle-stimulating hormone signaling pathway | The series of molecular signals mediated by follicle-stimulating hormone. |
FSHB, FSHR |
GO:0042700 | BP | luteinizing hormone signaling pathway | The series of molecular signals mediated by luteinizing hormone. |
EREG, LHCGR |
GO:0042701 | BP | progesterone secretion | The regulated release of progesterone, a steroid hormone, by the corpus luteum of the ovary and by the placenta. |
INHBA, FZD4 |
GO:0042703 | BP | menstruation | The cyclic, physiologic discharge through the vagina of blood and endometrial tissues from the nonpregnant uterus. |
FOXL2 |
GO:0042704 | BP | uterine wall breakdown | The sloughing of the endometrium and blood vessels during menstruation that results from a drop in progesterone levels. |
TGFB2 |
GO:0042711 | BP | maternal behavior | Female behaviors associated with the care and rearing of offspring. |
OXTR, GNAQ, PTEN, CREBRF |
GO:0042713 | BP | sperm ejaculation | The expulsion of seminal fluid, thick white fluid containing spermatozoa, from the male genital tract. |
ACVR2A, OXTR |
GO:0042719 | CC | mitochondrial intermembrane space protein transporter complex | Soluble complex of the mitochondrial intermembrane space composed of various combinations of small Tim proteins; acts as a protein transporter to guide proteins to the Tim22 complex for insertion into the mitochondrial inner membrane. |
TIMM10B |
GO:0042723 | BP | thiamine-containing compound metabolic process | The chemical reactions and pathways involving thiamine (vitamin B1), and compounds derived from it. |
SLC19A2, TPK1 |
GO:0042730 | BP | fibrinolysis | A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin. |
F2, PLG, PLAU, PLAT, FGA, FGB, FGG, KRT1, SERPINE1, SERPING1, ANXA2, PLAUR, TMPRSS6, CPB2 |
GO:0042731 | MF | PH domain binding | Interacting selectively and non-covalently with a PH domain (pleckstrin homology) of a protein, a domain of about 100 residues that occurs in a wide range of proteins involved in intracellular signaling or as constituents of the cytoskeleton. |
EPHA4, INPP5A |
GO:0042732 | BP | D-xylose metabolic process | The chemical reactions and pathways involving D-xylose, a naturally occurring plant polysaccharide. |
DCXR |
GO:0042733 | BP | embryonic digit morphogenesis | The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe. |
LRP5, TULP3, MYCN, GLI2, GLI3, BMP4, GJA1, CTNNB1, BMPR1A, WNT5A, ECE1, GNAQ, GNA12, ZBTB16, SMAD4, HDAC1, TWIST1, TMEM107, OSR1, LMBR1, HDAC2, CREBBP, LNP, IFT122, CHST11, MKS1, ZAK, INTU, B9D1 |
GO:0042734 | CC | presynaptic membrane | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. |
APBB1, GRM8, CASK, GRM6, FBXO45, FOSL1, SYT1, ADORA1, SNAP25, FMR1, KCNA1, GRIN2A, STX3, PICALM, GRM3, NECTIN1, ERC1, ZDHHC17, DENND1A, KCTD12, GPER1, GABBR1, NRXN1, RIMS2, SNCAIP |
GO:0042737 | BP | drug catabolic process | The chemical reactions and pathways resulting in the breakdown of a drug, a substance used in the diagnosis, treatment or prevention of a disease. |
CYP3A4, CYP2D6, CYP2C9, CYP3A5, FMO4 |
GO:0042738 | BP | exogenous drug catabolic process | The chemical reactions and pathways resulting in the breakdown of a drug that has originated externally to the cell or organism. |
CYP3A4, CYP2A6, CYP2C9, CYP2B6, NUDT15 |
GO:0042742 | BP | defense response to bacterium | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
IGLL5, TLR4, TLR3, COCH, HP, PPBP, S100A8, ISG15, MPO, S100A9, MBL2, ANXA3, PRG2, CEBPB, BCL3, IL10, CFP, SYK, SLC11A1, ROMO1, RAB1A, CCL20, CXCL6, HAMP, TMF1, PRKCD, TLR1, MICA, GBP6, MAVS, IFNE, DEFB104A, STAB2, CLEC4D, NR1H4, LYST, STAB1, ADAMTS5 |
GO:0042743 | BP | hydrogen peroxide metabolic process | The chemical reactions and pathways involving hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA. |
EGFR, DUOXA1, DUOXA2 |
GO:0042744 | BP | hydrogen peroxide catabolic process | The chemical reactions and pathways resulting in the breakdown of hydrogen peroxide (H2O2). |
MPO, GPX1, GPX3, PRDX6, PRDX2, HBB, HBA1, PRDX1, DUOX2, DUOX1 |
GO:0042745 | BP | circadian sleep/wake cycle | The cycle from wakefulness through an orderly succession of sleep states and stages that occurs on an approximately 24 hour rhythm. |
TH, AHCY |
GO:0042747 | BP | circadian sleep/wake cycle, REM sleep | A stage in the circadian sleep cycle during which dreams occur and the body undergoes marked changes including rapid eye movement, loss of reflexes, and increased pulse rate and brain activity. |
CST3, SRD5A1, STAR |
GO:0042748 | BP | circadian sleep/wake cycle, non-REM sleep | All sleep stages in the circadian sleep/wake cycle other than REM sleep. These stages are characterized by a slowing of brain waves and other physiological functions. |
BTBD9 |
GO:0042752 | BP | regulation of circadian rhythm | Any process that modulates the frequency, rate or extent of a circadian rhythm. A circadian rhythm is a biological process in an organism that recurs with a regularity of approximately 24 hours. |
PER1, ROCK2, TOP2A, CREB1, NR1D1, SFPQ, PPP1CC, PPARG, MAPK8, MAPK9, CSNK1D, CSNK1E, PRKAA2, PPP1CA, PPP1CB, PRKDC, ID2, CREM, PPARA, KLF10, NR1H3, HNRNPD, NR1D2, NONO, EZH2, CRY1, CCAR2, PSPC1, PROX1, OPN3, PPARGC1A, NOCT, TIMELESS, BTRC |
GO:0042753 | BP | positive regulation of circadian rhythm | Any process that activates or increases the frequency, rate or extent of a circadian rhythm behavior. |
ARNTL, RORA, NKX2-1, ARNTL2, BTRC, THRAP3 |
GO:0042754 | BP | negative regulation of circadian rhythm | Any process that stops, prevents, or reduces the frequency, rate or extent of a circadian rhythm behavior. |
SFPQ, CRY1, SUV39H2 |
GO:0042755 | BP | eating behavior | The specific behavior of an organism relating to the intake of food, any substance (usually solid) that can be metabolized by an organism to give energy and build tissue. |
AGRP, CCK, TH, UCHL1, IAPP, ADRB3, TRH, OXTR, STAT3, OPRL1, LEP, NMU, CPT1A, TCF15, NPY5R, BBS12 |
GO:0042756 | BP | drinking behavior | The specific behavior of an organism relating to the intake of liquids, especially water. |
APLN |
GO:0042758 | BP | long-chain fatty acid catabolic process | The chemical reactions and pathways resulting in the breakdown of long-chain fatty acids, a fatty acid with a chain length between C13 and C22. |
LIPE |
GO:0042759 | BP | long-chain fatty acid biosynthetic process | The chemical reactions and pathways resulting in the formation of long-chain fatty acids, any fatty acid with a chain length between C13 and C22. |
SCD, PLP1, SCD5, QKI, ELOVL6, MYO5A |
GO:0042760 | BP | very long-chain fatty acid catabolic process | The chemical reactions and pathways resulting in the breakdown of a fatty acid which has a chain length greater than C22. |
SLC27A2, ABCD3, ACADVL, SLC27A4 |
GO:0042761 | BP | very long-chain fatty acid biosynthetic process | The chemical reactions and pathways resulting in the formation of a fatty acid which has a chain length greater than C22. |
ELOVL7, HACD4, HACD2, ELOVL1, ELOVL4, ELOVL6, ELOVL5, HACD3 |
GO:0042765 | CC | GPI-anchor transamidase complex | An enzyme complex which in humans and yeast consists of at least five proteins; for example, the complex contains GAA1, GPI8, PIG-S, PIG-U, and PIG-T in human, and Gaa1p, Gab1p, Gpi8p, Gpi16p, and Gpi17p in yeast. Catalyzes the posttranslational attachment of the carboxyl-terminus of a precursor protein to a GPI-anchor. |
PIGK, PIGT, PIGU |